Piotr Harbut
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Piotr Harbut has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Atul Malhotra
Department of Medicine, University of California , San Diego, CA 92037
2 shared publications- Gordon Kim Prisk
Department of Medicine, University of California, San Diego, California, United States
2 shared publications - Kristina Kairaitis
Sleep Research Group, Charles Perkins Centre, University of Sydney, Sydney, Australia
2 shared publications - Robert A. Robles
Department of Respiratory and Sleep Medicine, Westmead Hospital, Sydney, New South Wales, Australia
2 shared publications - Terence C. Amis
Westmead Hospital
2 shared publications - Ajai K. Malhotra
Surgery, University of Vermont Medical Center, Burlington, Vermont, USA
1 shared publication
Latest Publications
- Open Access
- 27 December 2024
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 7 (1) , tzaf008
Quantitative assessment of lung opacities from CT of pulmonary artery imaging data in COVID-19 patients: artificial intelligence versus radiologist
Objectives: Artificial intelligence (AI) deep learning algorithms trained on non-contrast CT scans effectively detect and quantify acute COVID-19 lung involvement. Our study explored whether radiological contrast affects the accuracy of AI-measured lung opacities, potentially impacting clinical decisions. We compared lung opacity measurements from AI software with visual assessments by radiologists using CT pulmonary angiography (CTPA) images of early-stage COVID-19 patients. Methods: This prospective single-centre study included 18 COVID-19 patients who underwent CTPA due to suspected pulmonary embolism. Patient demographics, clinical data, and 30-day and 90-day mortality were recorded. AI tool (Pulmonary Density Plug-in, AI-Rad Companion Chest CT, SyngoVia; Siemens Healthineers, Forchheim, Germany) was used to estimate the quantity of opacities. Visual quantitative assessments were performed independently by 2 radiologists. Results: There was a positive correlation between radiologist estimations (r2 = 0.57) and between the AI data and the mean of the radiologists’ estimations (r2 = 0.70). Bland-Altman plot analysis showed a mean bias of +3.06% between radiologists and −1.32% between the mean radiologist vs AI, with no outliers outside 2×SD for respective comparison. : The AI protocol facilitated a quantitative assessment of lung opacities and showed a strong correlation with data obtained from 2 independent radiologists, demonstrating its potential as a complementary tool in clinical practice. Conclusion: In assessing COVID-19 lung opacities in CTPA images, AI tools trained on non-contrast images, provide comparable results to visual assessments by radiologists. Advances in knowledge: The Pulmonary Density Plug-in enables quantitative analysis of lung opacities in COVID-19 patients using contrast-enhanced CT images, potentially streamlining clinical workflows and supporting timely decision-making.
- 27 December 2024
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 7 (1) , tzaf008
Open AccessQuantitative assessment of lung opacities from CT of pulmonary artery imaging data in COVID-19 patients: artificial intelligence versus radiologist
Objectives: Artificial intelligence (AI) deep learning algorithms trained on non-contrast CT scans effectively detect and quantify acute COVID-19 lung involvement. Our study explored whether radiological contrast affects the accuracy of AI-measured lung opacities, potentially impacting clinical decisions. We compared lung opacity measurements from AI software with visual assessments by radiologists using CT pulmonary angiography (CTPA) images of early-stage COVID-19 patients. Methods: This prospective single-centre study included 18 COVID-19 patients who underwent CTPA due to suspected pulmonary embolism. Patient demographics, clinical data, and 30-day and 90-day mortality were recorded. AI tool (Pulmonary Density Plug-in, AI-Rad Companion Chest CT, SyngoVia; Siemens Healthineers, Forchheim, Germany) was used to estimate the quantity of opacities. Visual quantitative assessments were performed independently by 2 radiologists. Results: There was a positive correlation between radiologist estimations (r2 = 0.57) and between the AI data and the mean of the radiologists’ estimations (r2 = 0.70). Bland-Altman plot analysis showed a mean bias of +3.06% between radiologists and −1.32% between the mean radiologist vs AI, with no outliers outside 2×SD for respective comparison. : The AI protocol facilitated a quantitative assessment of lung opacities and showed a strong correlation with data obtained from 2 independent radiologists, demonstrating its potential as a complementary tool in clinical practice. Conclusion: In assessing COVID-19 lung opacities in CTPA images, AI tools trained on non-contrast images, provide comparable results to visual assessments by radiologists. Advances in knowledge: The Pulmonary Density Plug-in enables quantitative analysis of lung opacities in COVID-19 patients using contrast-enhanced CT images, potentially streamlining clinical workflows and supporting timely decision-making.
- 1 November 2023
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 135 (5) , 1012-1022
Increased intrapulmonary shunt and alveolar dead space post-COVID-19
Using novel methodology quantifying intrapulmonary shunt and alveolar dead space in COVID-19 patients up to 403 days after acute illness, 37% had increased intrapulmonary shunt and 86% had elevated alveolar dead space likely due to independent pathology. Elevated shunt was partially related to severe acute illness, and increased alveolar dead space was weakly related to increasing age. Ventilation was increased in the majority of patients regardless of previous disease severity. These results demonstrate persisting gas exchange abnormalities after recovery.
- 1 November 2023
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 135 (5) , 1012-1022
Increased intrapulmonary shunt and alveolar dead space post-COVID-19
Using novel methodology quantifying intrapulmonary shunt and alveolar dead space in COVID-19 patients up to 403 days after acute illness, 37% had increased intrapulmonary shunt and 86% had elevated alveolar dead space likely due to independent pathology. Elevated shunt was partially related to severe acute illness, and increased alveolar dead space was weakly related to increasing age. Ventilation was increased in the majority of patients regardless of previous disease severity. These results demonstrate persisting gas exchange abnormalities after recovery.
- 18 August 2022
- Published by H1 Connect
Faculty Opinions recommendation of Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS.
On the base of the volumetric capnometry, the authors show a strong correlation between elevated respiratory dead space and mortality in severe COVID-19 acute respiratory distress syndrome (ARDS). The coexisting elevation in D-dimer confirms the role of the procoagulant/thromboembolic component in the development of this life-threatening condition.
- 18 August 2022
- Published by H1 Connect
Faculty Opinions recommendation of Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS.
On the base of the volumetric capnometry, the authors show a strong correlation between elevated respiratory dead space and mortality in severe COVID-19 acute respiratory distress syndrome (ARDS). The coexisting elevation in D-dimer confirms the role of the procoagulant/thromboembolic component in the development of this life-threatening condition.
- 9 August 2021
- Published by H1 Connect
Faculty Opinions recommendation of Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia.
The authors, on the basis of a 12-compartment mathematical model, discuss and try to explain the pathological mechanisms underlying the respiratory impairment and silent hypoxia in acute COVID-19 pneumonia. The mechanisms discussed are multifactorial and include alteration in hypoxic pulmonary vasoconstriction, thrombosis and related perfusion redirection as well as ventilation/perfusion mismatching in the noninjured regions. Even paradoxical hyperperfusion of the affected region is postulated.
- 9 August 2021
- Published by H1 Connect
Faculty Opinions recommendation of Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia.
The authors, on the basis of a 12-compartment mathematical model, discuss and try to explain the pathological mechanisms underlying the respiratory impairment and silent hypoxia in acute COVID-19 pneumonia. The mechanisms discussed are multifactorial and include alteration in hypoxic pulmonary vasoconstriction, thrombosis and related perfusion redirection as well as ventilation/perfusion mismatching in the noninjured regions. Even paradoxical hyperperfusion of the affected region is postulated.
- 9 December 2020
- Published by H1 Connect
Faculty Opinions recommendation of Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease 2019.
This is an interesting methodological approach to lung physiological research. It makes important findings on the substantial rise of dead space in critically ill patients with severe COVID-19 pneumonia on the clinically applicable, non-invasive base. The individualised strategy in respiratory treatment is supposed to be recommended due to the large variability in lung recruitability.
- 9 December 2020
- Published by H1 Connect
Faculty Opinions recommendation of Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease 2019.
This is an interesting methodological approach to lung physiological research. It makes important findings on the substantial rise of dead space in critically ill patients with severe COVID-19 pneumonia on the clinically applicable, non-invasive base. The individualised strategy in respiratory treatment is supposed to be recommended due to the large variability in lung recruitability.
- 25 August 2020
- Published by H1 Connect
Faculty Opinions recommendation of Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
The authors point out the underlying mechanisms in acute lung injury induced by COVID-19 pneumonia. The important finding is that there is not only inflammation and thrombosis, but even pathological angiogenesis is involved. The study opens up new opportunities for research on potential therapeutic targets in the management of this severe condition.
- 25 August 2020
- Published by H1 Connect
Faculty Opinions recommendation of Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
The authors point out the underlying mechanisms in acute lung injury induced by COVID-19 pneumonia. The important finding is that there is not only inflammation and thrombosis, but even pathological angiogenesis is involved. The study opens up new opportunities for research on potential therapeutic targets in the management of this severe condition.
- 15 April 2020
- Published by H1 Connect
Faculty Opinions recommendation of COVID-19 pneumonia: different respiratory treatments for different phenotypes?
The authors discuss the concept of different pathological pathways of COVID-19 induced hypoxia compared to classic primary acute respiratory distress syndrome (ARDS). However not directly supported by clinical research, the clinical course and lung ventilatory findings presented by the authors are widely confirmed by the critical care practitioners involved in the care of COVID-19 patients with acute, hypoxic respiratory insufficiency. Respiratory care of hypoxic COVID-19 patients in need of invasive ventilatory support depends on the stage of the disease and can substantially differ from classic ARDS.
- 15 April 2020
- Published by H1 Connect
Faculty Opinions recommendation of COVID-19 pneumonia: different respiratory treatments for different phenotypes?
The authors discuss the concept of different pathological pathways of COVID-19 induced hypoxia compared to classic primary acute respiratory distress syndrome (ARDS). However not directly supported by clinical research, the clinical course and lung ventilatory findings presented by the authors are widely confirmed by the critical care practitioners involved in the care of COVID-19 patients with acute, hypoxic respiratory insufficiency. Respiratory care of hypoxic COVID-19 patients in need of invasive ventilatory support depends on the stage of the disease and can substantially differ from classic ARDS.
- 10 April 2020
- Published by H1 Connect
- Vol. 56 (1)
Faculty Opinions recommendation of Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators.
Filtering facepiece respirators (FFRs) are recommended for use as precautions against airborne pathogenic microorganisms; however, during pandemics demand for FFRs may far exceed availability. Reuse of FFRs following decontamination has been proposed but few reported studies have addressed the feasibility. Concerns regarding biocidal efficacy, respirator performance post decontamination, decontamination cost, and user safety have impeded adoption of reuse measures. This study examined the effectiveness of three energetic decontamination methods [ultraviolet germicidal irradiation (UVGI), microwave-generated steam, and moist heat] on two National Institute for Occupational Safety and Health-certified N95 FFRs (3M models 1860s and 1870) contaminated with H5N1. An aerosol settling chamber was used to apply virus-laden droplets to FFRs in a method designed to simulate respiratory deposition of droplets onto surfaces. When FFRs were examined post decontamination by viral culture, all three decontamination methods were effective, reducing virus load by > 4 log median tissue culture infective dose. Analysis of treated FFRs using a quantitative molecular amplification assay (quantitative real-time polymerase chain reaction) indicated that UVGI decontamination resulted in lower levels of detectable viral RNA than the other two methods. Filter performance was evaluated before and after decontamination using a 1% NaCl aerosol. As all FFRs displayed < 5% penetration by 300-nm particles, no profound reduction in filtration performance was caused in the FFRs tested by exposure to virus and subsequent decontamination by the methods used. These findings indicate that, when properly implemented, these methods effectively decontaminate H5N1 on the two FFR models tested and do not drastically affect their filtering function; however, other considerations may influence decisions to reuse FFRs.
- 10 April 2020
- Published by H1 Connect
- Vol. 56 (1)
Faculty Opinions recommendation of Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators.
Filtering facepiece respirators (FFRs) are recommended for use as precautions against airborne pathogenic microorganisms; however, during pandemics demand for FFRs may far exceed availability. Reuse of FFRs following decontamination has been proposed but few reported studies have addressed the feasibility. Concerns regarding biocidal efficacy, respirator performance post decontamination, decontamination cost, and user safety have impeded adoption of reuse measures. This study examined the effectiveness of three energetic decontamination methods [ultraviolet germicidal irradiation (UVGI), microwave-generated steam, and moist heat] on two National Institute for Occupational Safety and Health-certified N95 FFRs (3M models 1860s and 1870) contaminated with H5N1. An aerosol settling chamber was used to apply virus-laden droplets to FFRs in a method designed to simulate respiratory deposition of droplets onto surfaces. When FFRs were examined post decontamination by viral culture, all three decontamination methods were effective, reducing virus load by > 4 log median tissue culture infective dose. Analysis of treated FFRs using a quantitative molecular amplification assay (quantitative real-time polymerase chain reaction) indicated that UVGI decontamination resulted in lower levels of detectable viral RNA than the other two methods. Filter performance was evaluated before and after decontamination using a 1% NaCl aerosol. As all FFRs displayed < 5% penetration by 300-nm particles, no profound reduction in filtration performance was caused in the FFRs tested by exposure to virus and subsequent decontamination by the methods used. These findings indicate that, when properly implemented, these methods effectively decontaminate H5N1 on the two FFR models tested and do not drastically affect their filtering function; however, other considerations may influence decisions to reuse FFRs.
- 14 February 2020
- Published by H1 Connect
- Vol. 43 (2)
Faculty Opinions recommendation of Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients.
PURPOSE: To develop and validate a scale using variables easily obtained at the bedside for prediction of failure of noninvasive ventilation (NIV) in hypoxemic patients. METHODS: The test cohort comprised 449 patients with hypoxemia who were receiving NIV. This cohort was used to develop a scale that considers heart rate, acidosis, consciousness, oxygenation, and respiratory rate (referred to as the HACOR scale) to predict NIV failure, defined as need for intubation after NIV intervention. The highest possible score was 25 points. To validate the scale, a separate group of 358 hypoxemic patients were enrolled in the validation cohort. RESULTS: The failure rate of NIV was 47.8 and 39.4% in the test and validation cohorts, respectively. In the test cohort, patients with NIV failure had higher HACOR scores at initiation and after 1, 12, 24, and 48 h of NIV than those with successful NIV. At 1 h of NIV the area under the receiver operating characteristic curve was 0.88, showing good predictive power for NIV failure. Using 5 points as the cutoff value, the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy for NIV failure were 72.6, 90.2, 87.2, 78.1, and 81.8%, respectively. These results were confirmed in the validation cohort. Moreover, the diagnostic accuracy for NIV failure exceeded 80% in subgroups classified by diagnosis, age, or disease severity and also at 1, 12, 24, and 48 h of NIV. Among patients with NIV failure with a HACOR score of >5 at 1 h of NIV, hospital mortality was lower in those who received intubation at ≤12 h of NIV than in those intubated later [58/88 (66%) vs. 138/175 (79%); p = 0.03). CONCLUSIONS: The HACOR scale variables are easily obtained at the bedside. The scale appears to be an effective way of predicting NIV failure in hypoxemic patients. Early intubation in high-risk patients may reduce hospital mortality.
- 14 February 2020
- Published by H1 Connect
- Vol. 43 (2)
Faculty Opinions recommendation of Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients.
PURPOSE: To develop and validate a scale using variables easily obtained at the bedside for prediction of failure of noninvasive ventilation (NIV) in hypoxemic patients. METHODS: The test cohort comprised 449 patients with hypoxemia who were receiving NIV. This cohort was used to develop a scale that considers heart rate, acidosis, consciousness, oxygenation, and respiratory rate (referred to as the HACOR scale) to predict NIV failure, defined as need for intubation after NIV intervention. The highest possible score was 25 points. To validate the scale, a separate group of 358 hypoxemic patients were enrolled in the validation cohort. RESULTS: The failure rate of NIV was 47.8 and 39.4% in the test and validation cohorts, respectively. In the test cohort, patients with NIV failure had higher HACOR scores at initiation and after 1, 12, 24, and 48 h of NIV than those with successful NIV. At 1 h of NIV the area under the receiver operating characteristic curve was 0.88, showing good predictive power for NIV failure. Using 5 points as the cutoff value, the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy for NIV failure were 72.6, 90.2, 87.2, 78.1, and 81.8%, respectively. These results were confirmed in the validation cohort. Moreover, the diagnostic accuracy for NIV failure exceeded 80% in subgroups classified by diagnosis, age, or disease severity and also at 1, 12, 24, and 48 h of NIV. Among patients with NIV failure with a HACOR score of >5 at 1 h of NIV, hospital mortality was lower in those who received intubation at ≤12 h of NIV than in those intubated later [58/88 (66%) vs. 138/175 (79%); p = 0.03). CONCLUSIONS: The HACOR scale variables are easily obtained at the bedside. The scale appears to be an effective way of predicting NIV failure in hypoxemic patients. Early intubation in high-risk patients may reduce hospital mortality.